Scarica l'app Stockscreener
5.38
3.41%
-0.19
Dopo l'orario di chiusura:
5.38
Precedente Chiudi:
$5.57
Aprire:
$5.21
Volume 24 ore:
32,031
Relative Volume:
0.79
Capitalizzazione di mercato:
$33.03M
Reddito:
-
Utile/perdita netta:
$-71.07M
Rapporto P/E:
-10.98
EPS:
-0.49
Flusso di cassa netto:
$-63.98M
1 W Prestazione:
-17.99%
1M Prestazione:
-42.15%
6M Prestazione:
-10.33%
1 anno Prestazione:
-34.55%
Intervallo 1D:
$5.17
$5.88
Intervallo di 1 settimana:
$5.17
$6.73
Portata 52W:
$4.2701
$19.00
Vicarious Surgical Inc Stock (RBOT) Company Profile
Nome
Vicarious Surgical Inc
Settore
Industria
Telefono
(617) 868-1700
Indirizzo
78 FOURTH AVENUE, WALTHAM
Confronta RBOT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
5.38 | 33.03M | 0 | -71.07M | -63.98M | -0.49 |
|
ABT
Abbott Laboratories
|
124.86 | 216.55B | 41.95B | 13.40B | 6.35B | 7.65 |
|
SYK
Stryker Corp
|
345.34 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
BSX
Boston Scientific Corp
|
91.54 | 132.67B | 16.75B | 1.85B | 2.37B | 1.25 |
|
MDT
Medtronic Plc
|
83.15 | 106.28B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
69.00 | 40.63B | 5.72B | 4.17B | 259.90M | 6.97 |
Vicarious Surgical Inc Stock (RBOT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-03-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Iniziato | Credit Suisse | Outperform |
| 2021-12-07 | Iniziato | Cowen | Outperform |
| 2021-11-05 | Iniziato | Canaccord Genuity | Buy |
| 2021-10-18 | Iniziato | BTIG Research | Buy |
| 2021-10-07 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Vicarious Surgical Inc Borsa (RBOT) Ultime notizie
(RBOT) Long Term Investment Analysis - news.stocktradersdaily.com
RBOTVicarious Surgical Announces Reverse Stock Split - ADVFN
Vicarious Surgical President Randy Clark to Become Board Member - MPO-mag
Learn to Evaluate (RBOT) using the Charts - news.stocktradersdaily.com
Vicarious Surgical President Randy Clark to Transition to Board Member - citybiz
Vicarious Surgical president shifts to board role By Investing.com - Investing.com South Africa
Vicarious surgical CEO sells $1,275 in stock By Investing.com - Investing.com Australia
Vicarious Surgical Announces President Transition to Board Member Role - Ortho Spine News
Vicarious surgical CTO Khalifa Sammy sells $1,028 in stock By Investing.com - Investing.com Canada
Vicarious surgical CTO Khalifa Sammy sells $1,028 in stock - Investing.com
Vicarious surgical CEO sells $1,275 in stock - Investing.com
Vicarious Surgical president shifts to board role - Investing.com India
Vicarious Surgical announces president transition to board member role -March 24, 2025 at 04:31 pm EDT - MarketScreener
Strategic Leadership Shift: Vicarious Surgical President Elevates to Board Role After Key Achievements - Stock Titan
Vicarious Faces Another Delay for FDA Submission - MD+DI
Vicarious Surgical Inc (NYSE:RBOT) Sees Significant Growth in Short Interest - Defense World
Monogram robot wins FDA OK; Vicarious hit by supplier woes - MedTech Dive
Vicarious Surgical’s Earnings Call: Achievements and Challenges - TipRanks
Piper Sandler cuts Vicarious Surgical stock target to $8.50 By Investing.com - Investing.com Australia
Piper Sandler cuts Vicarious Surgical stock target to $8.50 - Investing.com India
BTIG maintains Neutral on Vicarious Surgical stock post-results By Investing.com - Investing.com Australia
BTIG maintains Neutral on Vicarious Surgical stock post-results - Investing.com
Vicarious Surgical Inc. (NYSE:RBOT) Q4 2024 Earnings Call Transcript - MSN
Vicarious Surgical reports net loss of USD 14.4M in Q4 2024 - Medical Buyer
Vicarious Surgical Inc (RBOT) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Cost ... By GuruFocus - Investing.com Canada
Vicarious Surgical Reports 2024 Financial Results and Progress - TipRanks
Earnings call transcript: Vicarious Surgical Q4 2024 financials and outlook - Investing.com
Vicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial Results - OrthoSpineNews
Earnings call transcript: Vicarious Surgical Q4 2024 financials and outlook By Investing.com - Investing.com Australia
Vicarious Surgical Inc. SEC 10-K Report - TradingView
Vicarious Surgical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Vicarious Surgical Names Sarah Romano as Finance Chief - MPO-mag
Vicarious Surgical names Sarah Romano as CFO - Medical Buyer
Vicarious Surgical (RBOT) Projected to Post Quarterly Earnings on Monday - The AM Reporter
(RBOT) Trading Report - news.stocktradersdaily.com
Vicarious Surgical Inc expected to post a loss of $2.69 a shareEarnings Preview - TradingView
Vicarious Surgical appoints Sarah Romano as CFO - MedTech Dive
Vicarious Surgical Appoints Sarah Romano as Chief Financial Officer - citybiz
Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer - OrthoSpineNews
Vicarious Surgical appoints Sarah Romano as CFO -March 13, 2025 at 10:22 am EDT - Marketscreener.com
Vicarious Surgical names Sarah Romano as new CFO - Investing.com India
Vicarious Surgical Appoints New Chief Financial Officer - TipRanks
Vicarious Surgical names Sarah Romano as new CFO By Investing.com - Investing.com South Africa
Vicarious Surgical Names Sarah Romano Finance Chief -March 13, 2025 at 08:54 am EDT - Marketscreener.com
Vicarious Surgical (RBOT) Expected to Announce Quarterly Earnings on Monday - Defense World
Vicarious Surgical CEO Adam Sachs sells $5,499 in stock - Investing.com India
Vicarious Surgical CEO Adam Sachs sells $5,499 in stock By Investing.com - Investing.com South Africa
Vicarious Surgical Inc Azioni (RBOT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):